US-based sciences company Cytiva has opened a new manufacturing facility and Experience Centre in Pune, India. The facility will double Cytiva s manufacturing capacity in India and offer training programmes to accelerate the development of novel therapeutics. The facility will produce bioprocessing equipment, while the Experience Centre will provide immersive training programmes on various technologies. Cytiva s move is in response to the rising demand for biologic medicines in India, with 65% of biopharma executives expecting a significant increase in biologics manufacturing in the next three years.
Olivier Loeillot President and Chief Commercial Officer WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE Healthcare Life Sciences
The baculovirus–insect cell expression system insect cells used in conjunction with the baculovirus
expression vector system (BEVS) remains a crucial technology for manufacturing large and complex
proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product
design, and versatility for a broad range of proteins.